mitochondrial complex I inhibitors (Mayo Clinic Foundation/Nanosyn)

N/A

Report date: 2025/06/11 11:03:51
NME

Base Information

Drug Namemitochondrial complex I inhibitors (Mayo Clinic Foundation/Nanosyn)
Drug Alias NameCP-2 (Mayo Clinic Foundation)C-594NSMC-00458C-458NSMC-00594
ClassificationSmall molecules
Mechanisms of ActionMitochondrial complex I (NADH dehydrogenase) inhibitorsNeuroprotectants
TargetsMitochondrial complex I (NADH dehydrogenase)
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A